Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Bienaime Jean Jacques
Relationship:  
City:   Palo Alto
State:   CA
   
Insider Summary:
  
   
Companies Owned :   7    
Direct Shares   539,854    

Indirect Shares

   247,533      
Direct Value   $43,056,670    

Indirect Value

   $21,938,850      
Total Shares   787,387      
Total Value   $64,995,519      


Biomarin Pharmaceutical Inc $41,992,185 Neurogesx Inc $0 Portola Pharmaceuticals Inc $12,729 Immunic Inc $22,570 Incyte Corp $887,749 Immunome Inc. $141,437 Biomarin Pharmaceutical Inc $41,992,185 Neurogesx Inc $0 Portola Pharmaceuticals Inc $12,729 Immunic Inc $22,570 Incyte Corp $887,749 Immunome Inc. $141,437
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    2   
    1    

     Stock price went up :
    1   
    0    
     Stock price went down :
    1   
    1    
   
     Gain/Loss Ratio :
   0.0   
   -1.0   
     Percentage Gain/Loss :
   -13.1%
 -5.5%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Biomarin Pharmaceutical Inc BMRN Director 2024-05-20 473,792 2024-05-20 247,533    Premium*  
            Neurogesx Inc NGSX Director 2011-07-26 21,748 0    Premium*  
            InterMune Inc ITMN Director 2014-09-29 0 2012-04-06 0    Premium*  
            Portola Pharmaceuticals Inc PTLA Director 2014-05-16 706 2013-05-28 0    Premium*  
            Immunic Inc IMUX Director 2018-09-24 18,500 2001-04-23 0    Premium*  
            Incyte Corp INCY Director 2023-06-14 15,493 0    Premium*  
            Immunome Inc. IMNM 2024-05-21 9,615 0    Premium*  
* Premium Members only  

Records found :    852         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 14 of 35
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2012-03-09 4 S $34.46 $516,867 D/D (15,000) 114,093 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2012-02-29 4 S $36.26 $36,258 D/D (1,000) 115,093 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2013-05-23 4 GD $0.00 $0 D/D 10,131 115,770 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2012-05-07 4 OE $9.86 $49,300 D/D 5,000 118,191 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2013-05-08 4 AS $65.88 $65,879 D/D (1,000) 118,317 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2013-04-30 4 S $63.74 $63,742 D/D (1,000) 119,317 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2013-03-01 4 AS $59.14 $59,140 D/D (1,000) 119,401 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2013-04-30 4 A $23.21 $21,256 D/D 916 120,317 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2013-02-27 4 S $56.46 $84,683 D/D (1,500) 120,401 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2012-02-23 4 S $35.31 $176,541 D/D (5,000) 121,093 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2012-05-02 4 OE $9.86 $98,600 D/D 10,000 123,191 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2012-05-03 4 OE $9.86 $98,600 D/D 10,000 123,191 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2012-05-04 4 OE $9.86 $98,600 D/D 10,000 123,191 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2011-05-12 4 A $0.00 $0 D/D 36,000 123,593 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2013-05-15 4 A $0.00 $0 D/D 37,800 125,901 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2011-09-28 4 AS $32.00 $32,000 D/D (1,000) 126,093 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2011-06-06 4 S $27.39 $54,772 D/D (2,000) 127,093 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2011-08-02 4 S $30.23 $242,136 D/D (8,000) 127,093 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2011-08-12 4 S $27.10 $81,288 D/D (3,000) 127,093 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2011-08-19 4 S $26.75 $53,496 D/D (2,000) 127,093 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2011-08-30 4 S $29.01 $58,018 D/D (2,000) 127,093 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2012-05-08 4 OE $9.86 $147,900 D/D 15,000 128,191 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2011-05-31 4 AS $28.00 $19,880 D/D (710) 129,093 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2011-08-19 4 OE $6.46 $12,920 D/D 2,000 129,093 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2011-08-30 4 OE $6.46 $12,920 D/D 2,000 129,093 0 -
  852  Records found
  1   2   3   4   5   6   7   8   9   10   11   12   13   14  15   16   17   18   19   20   21   22   23   24   25   26   27   28   29   30   31   32   33   34   35      
  Page 14 of 35  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us